Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 ...

And one of the best ways to cash in on that is to invest in stocks that can exceed the market's performance. Two that look ...

It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive ...

Vertex Pharmaceuticals shows promising signs despite a recent price drop. Strong fundamentals underscore its market position, ...

Oracle and Alphabet said on Thursday their cloud computing units have struck a deal to offer Google's Gemini artificial ...

As the Trump administration works to implement a “most-favored nation” policy, Lilly said it’s “rebalancing” drug prices to ...

The heritage British brand has been revived by a chairman whose impressive career before watchmaking includes a three-year ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

Anthropic’s developers recently upgraded the AI model Claude Sonnet 4 to support up to 1 million tokens of context, thereby ...

Vertex Pharmaceuticals Incorporated has been a hot topic lately, but it's crucial to dig into the details before investing.

If your current vacuum feels clumsy or ties you to the nearest outlet, this is a refresh that shows up every single day. The ...